Depression doesn’t always respond to regular treatment, and experts are looking at psychedelics such as esketamine and psilocybin, and electroconvulsive and magnetic therapies, as alternatives.
A diagnosis of treatment-resistant depression (TRD) sounds like the end of the road. Fortunately, it's not. "Depression, even if it proves to be stubborn, is a very treatable condition," says psychiatrist and psychotherapist Dr Mazda Adli, head of the affective disorders research division at Charité university hospital in Berlin. So if your doctor says your depression is "treatment-resistant," it doesn't mean nothing more can be done for you. The term is used when adequate dosages of at least tw
Clinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has announced that global psychedelic therapy and science experts Doctor Bill Richards, Dr Andrea Jungaberle and Professor Matthew Johnson have joined the advisory board of its newly-established subsidiary Clarion Clinics Group.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), a pharmaceutical company developing cannabis-infused drugs and psychedelic-assisted psychotherapy protocols,.
Berlin is the unofficial nightlife capital of the world. This makes it a magnet for partygoers looking for hedonistic release. But that excitement sometimes ends in tragedy, as in the case of a young American woman who died of a drug overdose at Berghain, the city’s most iconic club.